press_release_image

Irritable Bowel Syndrome Market is Expected to Reach $3.07 bn by 2026

The Irritable Bowel Syndrome Market was valued at US$1.47 billion in the year 2018 and is estimated to reach US$3.07 billion by 2026, at a CAGR of 9.66%. Irritable Bowel Syndrome (IBS) is a debilitating gastrointestinal disorder characterized by Abdominal pain, Bloating, Constipation, and Diarrhea. IBS quintessentially alters the bowel movement...   Read More

19 December, 2019

press_release_image

Peptic Ulcer Drugs Market is Expected to Reach $5.99 bn by 2026

The Peptic Ulcer Drugs Market was valued at US $4.76 billion in the year 2018 and is estimated to reach US $5.99 billion by 2026, at a CAGR of 2.92%. Peptic ulcers are ulcers on lining of stomach, lower esophagus, or small intestine causing abdominal discomfort. These are caused due to erosion from stomach acids and inflammation by He...   Read More

19 December, 2019

press_release_image

Sickle cell anemia Treatment Market is Expected to Reach $6.46 bn by 2026

The Sickle Cell Anemia Treatment Market was valued at US$2.26 billion in the year 2018 and is estimated to reach US$6.46 billion by 2026, at a CAGR of 14.05%. Sickle Cell Anemia is an autosomal recessive disorder caused by a mutation in the hemoglobin-β gene found on chromosome 11, due to which the red blood cells become sickle or crescent...   Read More

19 December, 2019

press_release_image

Dry Eye Syndrome Treatment Market is Expected to Reach $5.68 bn by 2026

The Dry Eye Syndrome Treatment Market was valued at US $3.34 billion in the year 2018 and is estimated to reach US $5.68 billion by 2026, at a CAGR of 6.87%. Dry Eye Syndrome is the dryness of eyes and can also be denoted as keratoconjunctivitis sicca (KCS). It is caused by inadequate moisture or lubrication of the eye and inadequate and i...   Read More

16 December, 2019

press_release_image

Haemophilia Treatment Market is Expected to Reach $16.16 bn by 2026

The Haemophilia Treatment Market was valued at US$10.84 billion in the year 2018 and is estimated to reach US$16.16 billion by 2026, at a CAGR of 5.12%. Haemophilia is an X-linked recessive bleeding disorder characterized by a mutation in the X-chromosome. The disorder is more prevalent in the male population as the mutation occurs in the only X...   Read More

16 December, 2019

press_release_image

Thyroid Disorders Treatment Market is Expected to Reach $ 2.67 bn by 2026

The Thyroid Disorders Treatment Market was valued at around US$2.1 billion at the end of 2018. The revenue is said to engross over US$2.67 billion by 2026, with a CAGR of 3.52%. The thyroid gland is one of the glands which influences all the metabolic processes in our entire body through its secretions. Hypothyroidism (less secretion of the thy...   Read More

16 December, 2019

press_release_image

Peripheral Neuropathy Treatment Market is Expected to Reach $ 1.99 bn by 2026

The Peripheral Neuropathy (PN) Treatment Market was valued at around US$1.54 billion at the end of 2018. The revenue is expected to cross US$1.99 billion by 2026 at a CAGR of 3.29%. Peripheral Neuropathy is a condition that is characterized by damage to the peripheral nervous system. The condition often related to pain in the hand or legs, that...   Read More

16 December, 2019

press_release_image

Digital Microscopes Market is Expected to Reach $ 2.7 bn by 2026

The Digital Microscope Market was valued at US$1.7 billion in the year 2018 and is estimated to reach US$2.7 billion by 2026, at a CAGR of 5.95%. A digital microscope is a combination of a traditional optical microscope, digital multimedia, and digital processing technology. Digital microscopy imaging technology includes optical components for...   Read More

29 November, 2019

press_release_image

Gaucher's Disease Treatment Market is Expected to Reach $ 1.67 bn by 2026

The Gaucher’s Disease Treatment Market was valued at US$1.51 billion in the year 2018 and is estimated to reach US$1.67 billion by 2026, at a CAGR of 1.22%. Gaucher’s Disease (GD), is an autosomal recessive disorder characterized by the accumulation of fatty substances especially in the liver, spleen, lungs, kidney and bone marrow d...   Read More

12 November, 2019

press_release_image

Chronic Obstructive Pulmonary Disease Drugs Market is Expected to Reach $ 14.27 bn by 2026

The Chronic Obstructive Pulmonary Disease (COPD) was valued at US $10.78 billion in the year 2018 and is estimated to reach US $14.27 billion by 2026, at a CAGR of 3.57%. Chronic Obstructive Pulmonary Disease (COPD) is a chronic inflammatory lung disease that causes airflow obstruction and breathing difficulties. COPD is characterized by e...   Read More

12 November, 2019